Recent Security Class Actions

Organon & Co. Common Stock (NYSE: OGN)

47 Days left to seek lead plaintiff status.

Company Name:Organon & Co. Common Stock
Stock Symbol:NYSE: OGN
Class Period Start:10/31/2024
Class Period End (inclusive):04/30/2025
Filing Deadline:07/22/2025

The Complaint alleges that Defendants provided these overwhelmingly positive statements to investors while, at the same time, disseminating materially false and misleading statements and/or concealing material adverse facts concerning the true state of the Company’s priorities, particularly, related to capital allocation through quarterly dividends. The Complaint further alleges that Defendants concealed the high priority of Organon’s debt reduction strategy following the Company’s acquisition of Dermavant, resulting in a 70% decrease for the regular quarterly dividend.

Organon & Co. Common Stock (NYSE: OGN) Claim Form

Name(Required)
Address
This field is for validation purposes and should be left unchanged.